NRX Pharmaceuticals, Inc. Stock Issued During Period, Value, Other
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- NRX Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2020-12-31 was -$41.34K.
- NRX Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2020-09-30 was $0.00.
- NRX Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2020-06-30 was $0.00.
- NRX Pharmaceuticals, Inc. stock issued during period, value, other for the quarter ending 2020-03-31 was -$1.50M.
- NRX Pharmaceuticals, Inc. stock issued during period, value, other for fiscal 2020 was -$1.54M.
| Period end | Stock Issued During Period, Value, Other 3 month | Stock Issued During Period, Value, Other 12 month |
|---|---|---|
| 2020-12-31 | -$41.34K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-14 | -$1.54M 10-K/A · filed 2021-05-14 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | |
| 2020-03-31 | -$1.50M 10-Q · filed 2021-05-21 | |
| 2019-09-30 | -$147.99K 10-Q · filed 2020-11-16 | |
| 2019-06-30 | -$367.23K 10-Q · filed 2020-11-16 | |
| 2019-03-31 | -$187.97K 10-Q · filed 2020-11-16 | |
| 2018-09-30 | -$28.08K 10-Q · filed 2019-11-14 | -$36.95K derived: sum of 4 quarters · filed 2019-11-14 |
| 2018-06-30 | $6.61K 10-Q · filed 2019-11-14 | |
| 2018-03-31 | -$15.48K 10-Q · filed 2019-11-14 | |
| 2017-12-31 | $0.00 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |